936091-15-5
936091-15-5 structure
- Name: TG-46
- Chemical Name: N-tert-butyl-3-[[5-methyl-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide
- CAS Number: 936091-15-5
- Molecular Formula: C26H34N6O3S
- Molecular Weight: 510.652
- Catalog: Signaling Pathways Epigenetics JAK
- Create Date: 2018-12-25 19:52:39
- Modify Date: 2025-08-25 14:57:01
-
JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1].
| Name | N-tert-butyl-3-[[5-methyl-2-[4-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide |
|---|---|
| Synonyms |
EX-8668
RS0111 3-[(5-Methyl-2-{[4-(4-morpholinylmethyl)phenyl]amino}-4-pyrimidinyl)amino]-N-(2-methyl-2-propanyl)benzenesulfonamide Benzenesulfonamide,N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino] Benzenesulfonamide, N-(1,1-dimethylethyl)-3-[[5-methyl-2-[[4-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]- N-tert-butyl-3-(5-methyl-2-(4-(morpholinomethyl)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide TG-46 |
| Description | JAK-IN-35 (compound TG46) is a JAK2 inhibitor that canb be used in cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Wenge Zhu, et al. Combination therapy for treating cancer. Patent WO2018187485A1. |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 687.5±65.0 °C at 760 mmHg |
| Molecular Formula | C26H34N6O3S |
| Molecular Weight | 510.652 |
| Flash Point | 369.6±34.3 °C |
| Exact Mass | 510.241302 |
| PSA | 120.09000 |
| LogP | 1.83 |
| Vapour Pressure | 0.0±2.1 mmHg at 25°C |
| Index of Refraction | 1.621 |